FDANonrulemakingFDA-2015-D-1211

Who commented on this docket

Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products

1 organizations filed 2 public comments on Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products, at the Food and Drug Administration. The comment window closed 1315d ago.

Organizations
1
Comments
2
RIN
—
Comment window
closed 1315d ago

Abstract

Draft Guidance for Industry; Availability

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.